DK0519820T3 - Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration - Google Patents

Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration

Info

Publication number
DK0519820T3
DK0519820T3 DK92401694.2T DK92401694T DK0519820T3 DK 0519820 T3 DK0519820 T3 DK 0519820T3 DK 92401694 T DK92401694 T DK 92401694T DK 0519820 T3 DK0519820 T3 DK 0519820T3
Authority
DK
Denmark
Prior art keywords
indapamide
oral administration
prolonged release
matrix tablet
allows prolonged
Prior art date
Application number
DK92401694.2T
Other languages
English (en)
Inventor
Alain Cuine
De Barochez Bruno Huet
David Guez
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0519820T3 publication Critical patent/DK0519820T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92401694.2T 1991-06-18 1992-06-18 Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration DK0519820T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107400A FR2677886B1 (fr) 1991-06-18 1991-06-18 Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.

Publications (1)

Publication Number Publication Date
DK0519820T3 true DK0519820T3 (da) 1996-04-22

Family

ID=9413931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92401694.2T DK0519820T3 (da) 1991-06-18 1992-06-18 Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration

Country Status (14)

Country Link
US (1) US5334392A (da)
EP (1) EP0519820B1 (da)
JP (1) JP2638389B2 (da)
AT (1) ATE131050T1 (da)
AU (1) AU651894B2 (da)
CA (1) CA2071408C (da)
DE (1) DE69206495T2 (da)
DK (1) DK0519820T3 (da)
ES (1) ES2083119T3 (da)
FR (1) FR2677886B1 (da)
GR (1) GR3019017T3 (da)
HK (1) HK56397A (da)
IE (1) IE72192B1 (da)
ZA (1) ZA924482B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0800384T3 (da) * 1994-12-14 2001-04-17 Enbalt Trading Ltd Pharmaceutiske tabletformuleringer til direkte kompression
AU5609998A (en) * 1997-01-10 1998-08-03 Abbott Laboratories Tablet for the controlled release of active agents
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
CA2519556C (en) 2003-04-21 2011-01-18 Benjamin Oshlack Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
CA2532714C (en) * 2003-08-04 2010-11-16 Kyorin Pharmaceutical Co., Ltd. Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
PL1691892T3 (pl) * 2003-12-09 2007-07-31 Euro Celtique Sa Odporna na fizyczne manipulowanie, współwytłaczana postać dawkowania zawierająca środek aktywny i środek przeciwdziałający oraz sposób wytwarzania tej postaci
US8883204B2 (en) 2003-12-09 2014-11-11 Purdue Pharma L.P. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
JP2007530684A (ja) 2004-03-30 2007-11-01 ユーロ−セルティーク エス．エイ． 吸着剤と逆作用薬とを含有する不正使用防止投与剤型
FR2878748B1 (fr) * 2004-12-07 2007-03-09 Arrow Generiques Soc Par Actio Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation
DE102004062257A1 (de) 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
US20090264495A1 (en) * 2005-02-17 2009-10-22 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
EA013472B1 (ru) * 2007-10-19 2010-04-30 Закрытое Акционерное Общество "Канонфарма Продакшн" Матричная таблетка с пролонгированным высвобождением индапамида, способ ее получения и способ лечения
EP2448406B1 (en) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
EP2380561A1 (en) 2010-04-21 2011-10-26 LEK Pharmaceuticals d.d. Extended release formulation comprising indapamide
US8501009B2 (en) 2010-06-07 2013-08-06 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
US20120040008A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
AU2012318561B2 (en) 2011-10-07 2017-04-20 Outset Medical, Inc. Heat exchange fluid purification for dialysis system
EP2842711B1 (en) * 2013-08-26 2018-10-10 Airbus Operations GmbH Apparatus and method for producing a composite material aircraft component
CN104324013B (zh) * 2014-10-30 2017-09-26 黄山中皇制药有限公司 吲达帕胺缓释剂的制备工艺
CN111150713B (zh) * 2018-11-07 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法
CN112370433A (zh) * 2020-12-07 2021-02-19 石家庄市华新药业有限责任公司 一种吲达帕胺缓释片及其制备方法
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203691A (en) * 1968-03-06 1970-09-03 Science Union & Cie New disubstituted n-amino indoline derivatives and process for preparing them
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
EP0153105B1 (en) * 1984-02-10 1992-09-09 Benzon Pharma A/S Diffusion coated multiple-units dosage form
EP0178299A4 (en) * 1984-03-21 1987-04-28 Key Pharma DOSAGE FORM FOR NAPROXYN FOR PERMANENT ADMINISTRATION IN THE MOUTH.
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation
IT1187750B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Also Published As

Publication number Publication date
JP2638389B2 (ja) 1997-08-06
CA2071408A1 (fr) 1992-12-19
ATE131050T1 (de) 1995-12-15
HK56397A (en) 1997-05-09
IE72192B1 (en) 1997-03-26
ES2083119T3 (es) 1996-04-01
EP0519820B1 (fr) 1995-12-06
FR2677886B1 (fr) 1995-03-31
ZA924482B (en) 1993-08-18
US5334392A (en) 1994-08-02
CA2071408C (fr) 2001-06-12
JPH05186346A (ja) 1993-07-27
DE69206495T2 (de) 1996-07-25
GR3019017T3 (en) 1996-05-31
AU651894B2 (en) 1994-08-04
DE69206495D1 (de) 1996-01-18
AU1834392A (en) 1992-12-24
EP0519820A1 (fr) 1992-12-23
IE921952A1 (en) 1992-12-30
FR2677886A1 (fr) 1992-12-24

Similar Documents

Publication Publication Date Title
DK0519820T3 (da) Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration
NO912607D0 (no) Oral, fast farmasoeytisk doseringsform med programmert frigivelse.
NO971206D0 (no) Forlenget-frigjöringsformulering
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
FI924589A (fi) Smakmaskering av ibuprofen med virvelbaeddbetaeckning
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
DE68911473T2 (de) Arzneimittelformulierungen.
DE69523438T2 (de) Orale metoprolol-dosisform des typs "einmal täglich"
NO933854L (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
ES551635A0 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
DK0668290T3 (da) Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
ES1014509Y (es) Dispositivo para la administracion de farmacos por via uretral.
ES1015118Y (es) Dispositivo perfeccionado para la higiene dental.
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
NO924472L (no) Nikotinylalanin som terapeutisk middel med virkning paa sentralnervesystemet
MX9203583A (es) Composicion farmaceutica de liberacion prolongada a base de 9,10-dihidro-alcaloides.
ES1019422Y (es) Dispositivo para la higiene dental.
DK161990D0 (da) Substituerede phenylethanolaminer, anvendelse af saadanne som laegemidler og som ydelsesfremmende midler til dyr samt fremgangsmaade til deres fremstilling